-
Artificial Intelligence Characterizes CancerAt the AACR Annual Meeting 2018, researchers at Google compared the speed and accuracy of human pathologists and computer algorithms in diagnosing and grading cancer.
by Kevin McLaughlin
-
Non–Small Cell Lung Cancer Takes Center StageA trio of clinical trials at the AACR Annual Meeting spotlight new avenues for non-small cell lung cancer treatment.
by Brad Jones
-
Cancer Researchers Offer Reasons for OptimismCancer researchers and patient advocates spoke about progress against cancer at a public education forum sponsored by the American Association for Cancer Research.
by Kevin McLaughlin
-
Pembrolizumab Shows Further Promise for MelanomaIn a phase III clinical trial, pembrolizumab yielded a 75.4 percent recurrence-free survival rate after 12 months among patients whose stage III melanoma tumors had been fully resected.
by Brad Jones
-
The Evolving Role of Patient AdvocacyAACR’s Scientist↔Survivor Program marks a milestone as patient advocates continue to shape research and policy.
by Marci A. Landsmann
-
An Advocate’s Guide to Attending Scientific MeetingsTwo graduates of the AACR Scientist↔Survivor Program share tips for getting the most out of large scientific conferences.
by Bob Riter and Carole Baas
-
Making Decisions About Breast SurgeryPatients who opt for breast reconstruction after mastectomy tend to overestimate how happy they will be with the results, while those who do not get reconstruction tend to underestimate their future satisfaction.
by Cici Zhang
-
A Better Way to Screen for Lynch Syndrome?Researchers say a next-generation sequencing test could improve screening in colorectal cancer patients for a hereditary syndrome that raises cancer risk. Some experts have concerns.
by Cheryl Platzman Weinstock
-
Making Sense of Cancer ProgressCancer Today editor Kevin McLaughlin contemplates what it means to report on cancer research advances when so many continue to die of the disease.
by Kevin McLaughlin
-
A Book Club for Cancer Survivors and CaregiversShare your experiences as we discuss “A Cure Within” in a Cancer Today Facebook group.
by Marci A. Landsmann
Most pancreatic ductal adenocarcinoma cases initially considered to be stage I are changed to a higher stage after surgery.
by Taneia Surles
Understanding How High and Low Testosterone Levels Can Treat Prostate CancerUsing high-dose testosterone after prostate cancer stops responding to androgen deprivation therapy can stop tumor growth.
by Sandra Gordon
Financial Screenings for People with CancerCancer patients say they want to be asked about their financial needs on a regular basis.
by Pamela Appea
Let Me Tell You a Story About the Power of Medical ResearchTen-year-old Michael Methner told his story about being diagnosed with optic nerve glioma at the AACR’s Rally for Medical Research.
by Cancer Research Catalyst
-
AACR Grant Propels Progress in Immunotherapy ResearchA grant from the American Association for Cancer Research (AACR) helped Marco Ruella, MD, develop a new approach to immunotherapy.
-
Self-screening for Cancer: Home Sweet HomeNew cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening.
Alexis Browning
